SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Sees Significant Drop in Short Interest

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) was the target of a large decrease in short interest during the month of February. As of February 27th, there was short interest totaling 616,003 shares, a decrease of 21.2% from the February 12th total of 781,872 shares. Approximately 11.8% of the shares of the stock are sold short. Based on an average trading volume of 80,740 shares, the days-to-cover ratio is presently 7.6 days. Based on an average trading volume of 80,740 shares, the days-to-cover ratio is presently 7.6 days. Approximately 11.8% of the shares of the stock are sold short.

SPDR S&P Pharmaceuticals ETF Trading Up 0.9%

Shares of XPH traded up $0.50 during trading hours on Monday, reaching $53.75. 17,774 shares of the company’s stock traded hands, compared to its average volume of 115,517. SPDR S&P Pharmaceuticals ETF has a 12 month low of $35.22 and a 12 month high of $58.84. The stock has a market cap of $279.50 million, a PE ratio of 14.28 and a beta of 0.60. The firm’s 50 day simple moving average is $56.40 and its 200-day simple moving average is $52.74.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Advisory Services Network LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter worth $34,000. Team Financial Group LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth $56,000. Kestra Advisory Services LLC purchased a new position in SPDR S&P Pharmaceuticals ETF in the fourth quarter worth $151,000. Rockport Wealth LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF during the second quarter valued at about $203,000. Finally, Vista Investment Management bought a new stake in SPDR S&P Pharmaceuticals ETF during the fourth quarter worth about $223,000.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.